GNE-617

CAS No. 1362154-70-8

GNE-617( GNE-617 | GNE 617 | GNE617 )

Catalog No. M17972 CAS No. 1362154-70-8

GNE-617, a specific NAMPT inhibitor(IC50=5 nM), shows potency in xenograft models of cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 69 In Stock
10MG 113 In Stock
25MG 207 In Stock
50MG 332 In Stock
100MG 494 In Stock
500MG 1071 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GNE-617
  • Note
    Research use only, not for human use.
  • Brief Description
    GNE-617, a specific NAMPT inhibitor(IC50=5 nM), shows potency in xenograft models of cancer.
  • Description
    GNE-617 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with IC50 value of 5nM. Prolonged inhibition of nicotinamide phosphoribosyltransferase (NAMPT) is a strategy for targeting cancer metabolism.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GNE-617 | GNE 617 | GNE617
  • Pathway
    MAPK/ERK Signaling
  • Target
    JNK
  • Recptor
    NAMPT
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1362154-70-8
  • Formula Weight
    427.43
  • Molecular Formula
    C21H15F2N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 42.85 mg/mL; 100.25 mM
  • SMILES
    C1=CC(=CC=C1CNC(=O)C2=CN3C=CN=C3C=C2)S(=O)(=O)C4=CC(=CC(=C4)F)F
  • Chemical Name
    N-(4-((3,5-difluorophenyl)sulfonyl)benzyl)imidazo[1,2-a]pyridine-6-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shames DS, et al. Loss of NAPRT1 Expression by Tumor-specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors. Clin Cancer Res. 2013 Dec 15;19(24):6912-23.
molnova catalog
related products
  • c-JUN peptide

    Peptide comprising residues 33 - 57 of the JNK binding (δ) domain of human c-Jun. Disrupts JNK/c-Jun interaction leading to inhibition of serum-induced c-Jun phosphorylation, up-regulation of p21cip/waf and modulation of inflammatory gene expression. Specifically induces apoptosis in HeLa tumor cells.

  • JIP-1 (153-163)

    Peptide inhibitor of c-Jun N-terminal kinase (JNK), based on residues 153-163 of JNK-interacting protein-1 (JIP-1). Binds to JNK with affinity in the micromolar range and minimally inhibits p38 and ERK.

  • IQ3

    IQ3 is a selective inhibitor of JNK3(JNK3, JNK1 and JNK2 with Kd of 66 nM, 240 nM and 290 nM, respectively).